We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

100 hedge funds and large institutions have $1.05B invested in Longboard Pharmaceuticals, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 49 increasing their positions, 27 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

81% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 27

28% more capital invested

Capital invested by funds: $820M → $1.05B (+$229M)

5% less funds holding

Funds holding: 105 → 100 (-5)

17% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 24

73% less call options, than puts

Call options by funds: $235K | Put options by funds: $878K

Holders
100
Holders Change
-5
Holders Change %
-4.76%
% of All Funds
1.44%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.07%
New
20
Increased
49
Reduced
27
Closed
24
Calls
$235K
Puts
$878K
Net Calls
-$643K
Net Calls Change
+$425K

Top Buyers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
+$13.4M
2
BlackRock
BlackRock
New York
+$9.9M
3
Pictet Asset Management
Pictet Asset Management
Switzerland
+$6.65M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.73M
5
EA
Emerald Advisers
Pennsylvania
+$4.51M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$11.1M
2
Millennium Management
Millennium Management
New York
-$7.16M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.05M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.78M
5
AIC
AWM Investment Company
New York
-$4.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
101
Walleye Capital
New York
– -$4.28M -198,310 Closed
ACM
102
Altium Capital Management
New York
– -$3.67M -170,000 Closed
Citadel Advisors
103
Citadel Advisors
Florida
– -$2.91M -147,323 Closed
MIM
104
Monashee Investment Management
Massachusetts
– -$2.16M -100,000 Closed
Renaissance Technologies
105
Renaissance Technologies
New York
– -$1.54M -71,400 Closed
Qube Research & Technologies (QRT)
106
Qube Research & Technologies (QRT)
United Kingdom
– -$1.19M -55,137 Closed
Norges Bank
107
Norges Bank
Norway
– -$864K -40,000 Closed
TI
108
Trexquant Investment
Connecticut
– -$551K -25,501 Closed
Jacobs Levy Equity Management
109
Jacobs Levy Equity Management
New Jersey
– -$515K -23,853 Closed
CSS
110
Cubist Systematic Strategies
Connecticut
– -$496K -22,949 Closed
SEI Investments
111
SEI Investments
Pennsylvania
– -$429K -19,861 Closed
GCP
112
GSA Capital Partners
United Kingdom
– -$413K -19,110 Closed
AIG
113
American International Group
New York
– -$265K -12,283 Closed
DM
114
Deerfield Management
New York
– -$208K -9,624 Closed
DA
115
Denali Advisors
California
– -$201K -9,300 Closed
SG Americas Securities
116
SG Americas Securities
New York
– -$132K -6,102 Closed
ACM
117
ADAR1 Capital Management
Texas
– -$98.9K -4,580 Closed
Simplex Trading
118
Simplex Trading
Illinois
– -$33.3K -1,689 Closed
PD
119
Point72 (DIFC)
United Arab Emirates
– -$33.9K -1,569 Closed
MLICM
120
Metropolitan Life Insurance Company (MetLife)
New York
– -$29.3K -1,358 Closed
IC
121
Ikarian Capital
Texas
– -$5.1K -236 Closed
LF
122
LifeSteps Financial
California
– -$4.32K -200 Closed
AWM
123
Avior Wealth Management
Nebraska
– -$43 -2 Closed
Carson Wealth (CWM LLC)
124
Carson Wealth (CWM LLC)
Nebraska
– +$20 +1 New
1 2 3 4
5

LBPH Hedge Fund Activity: Q2 2024 in Review

100 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q2 2024, worth a combined $1.05B — up 28% from $820M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of LBPH and 20 opened new positions — a net loss of 4 holders — while 27 trimmed existing stakes and 49 added.

The largest buyer was Viking Global Investors, adding an estimated $13.4M. The largest seller was Cormorant Asset Management, cutting an estimated $11.1M.

  • 100 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q2 2024, down from 105 in Q1 2024.
  • Funds reported $1.05B of Longboard Pharmaceuticals, Inc. Common Stock stock for Q2 2024, up 28% quarter-over-quarter.
  • 20 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q2 2024 and 24 closed out, a net change of -4 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q2 2024 was Viking Global Investors, an estimated $13.4M added.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q2 2024 was Cormorant Asset Management, an estimated $11.1M sold.

Based on aggregated 13F filings for Q2 2024.